PUBLICATIONS · 16860852
Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Gynecol Oncol
- Publication date
- 2006 Sep
- First author
- Bell J
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Gynecol Oncol. 2006 Sep;102(3):415-7. doi: 10.1016/j.ygyno.2006.08.001.
- note
- Source null
- related pmid
- 16979430
- relationship
- Comment in
- citation
- Gynecol Oncol. 2007 Apr;105(1):279-80; author reply 280-1. doi: 10.1016/j.ygyno.2007.01.006.
- note
- Source null
- related pmid
- 17291570
- relationship
- Comment in
- citation
- Gynecol Oncol. 2007 May;105(2):555-6; author reply 556. doi: 10.1016/j.ygyno.2007.01.024.
- note
- Source null
- related pmid
- 17306342
- relationship
- Comment in
Authors and identifiers
- name
- Bell J
- type
- Author
- name
- Brady MF
- type
- Author
- name
- Young RC
- type
- Author
- name
- Lage J
- type
- Author
- name
- Walker JL
- type
- Author
- name
- Look KY
- type
- Author
- name
- Rose GS
- type
- Author
- name
- Spirtos NM
- type
- Author
- name
- Gynecologic Oncology Group
- type
- CollectiveName
Complete bibliographic record and source provenance
- authors
- name
- Bell J
- type
- Author
- name
- Brady MF
- type
- Author
- name
- Young RC
- type
- Author
- name
- Lage J
- type
- Author
- name
- Walker JL
- type
- Author
- name
- Look KY
- type
- Author
- name
- Rose GS
- type
- Author
- name
- Spirtos NM
- type
- Author
- name
- Gynecologic Oncology Group
- type
- CollectiveName
- bibliography ids
- nci-bib-b1c1e73b3f4c07254c977385
- book metadata
- content sha256
- 2797fb0a1ad1bedb6ea3de8bfb826d5f15972abf8831d1bcd6baa292572c6ad0
- document type
- citation
- dois
- 10.1016/j.ygyno.2006.06.013
- electronic publication date
- display
- 2006 Jul 24
- precision
- day
- year
- 2006
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:16860852
- immutable id
- pubmed:16860852@2797fb0a1ad1bedb6ea3de8bfb826d5f15972abf8831d1bcd6baa292572c6ad0
- journal
- abbreviation
- Gynecol Oncol
- issn electronic
- Source null
- issn print
- 0090-8258
- issue
- 3
- name
- Gynecologic oncology
- nlm unique id
- 0365304
- pages
- 432-9
- volume
- 102
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Gynecol Oncol. 2006 Sep;102(3):415-7. doi: 10.1016/j.ygyno.2006.08.001.
- note
- Source null
- related pmid
- 16979430
- relationship
- Comment in
- citation
- Gynecol Oncol. 2007 Apr;105(1):279-80; author reply 280-1. doi: 10.1016/j.ygyno.2007.01.006.
- note
- Source null
- related pmid
- 17291570
- relationship
- Comment in
- citation
- Gynecol Oncol. 2007 May;105(2):555-6; author reply 556. doi: 10.1016/j.ygyno.2007.01.024.
- note
- Source null
- related pmid
- 17306342
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 16860852
- provenance
- batch id
- 2c499a3b9f4867a74c49
- provider
- NCBI PubMed ESummary
- record sha256
- ccdb4dccd1d975f68d83d8f1fb71d5e4cb50d31cb52e0c636e498d35df60653f
- response sha256
- 3b299651c5c5270455877b65b6e5acff71ad5f85103b7f9582efe63c52588326
- retrieved at
- 2026-09-09T23:46:08.887541+00:00
- publication date
- display
- 2006 Sep
- precision
- month
- year
- 2006
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study.
Preserved source evidence · Not medical advice
Triangle